The Series C funding round included participation from Saudi Arabia’s Public Investment Fund and an undisclosed American health insurance giant, and increases Babylon’s valuation to more than $2 billion. The investment will be used to advance the company’s diagnostic offerings and expand operations to the U.S. and Asia, Ali Parsa, PhD, founder and CEO, said in a statement.
Babylon’s software uses artificial intelligence to aid in the diagnosis and treatment of a wide variety of physical and mental health conditions. Its GP at Hand app, for example, provides NHS patients in the U.K. with a 24/7 telehealth chatbot and directs them toward appropriate primary care physicians if needed.
More articles on health IT:
IBM releases new blockchain network
11 vulnerabilities found in VxWorks operating system, affecting 2B medical devices
Louisiana physician network alerts 116,000 patients of ransomware attack
